Although Ohio voted in favor of legalizing recreational cannabis over two months ago, marijuana sales have yet to commence. This is because there have not been any rules defined regarding the legal sales of the recreational drug. According to Speaker of the Ohio House, Jason Stephens, he is working towards achieving a resolution on this issue in the spring. The Senate President, Matt Huffman, is also optimistic that the groups will reach a resolution on this matter within the next month. Several competing bills have been put forward, with both House Bill 86 and House Bill 354 looking to address the issue.
In 2016, after serving 13 years in prison, Weldon Angelos, who once worked with artists like Snoop Dogg and 2Pac, was released following President Obama's commutation, supported by Senators Cory Booker, Mike Lee, Rand Paul, prison reform advocate
Sales of medical cannabis in Ohio reached a new record high in 2023, with $484.4 million worth of products sold, but the growth rate of sales has been in decline, increasing by only 1.2% compared to the previous year.
Maryland residents spent a record $96.5m on cannabis products in December, according to data from the Maryland Cannabis Administration (MCA). Of that total, $61.5m came from recreational cannabis sales, while medical sales totaled around $35m for the month. Maryland has seen booming sales since the launch of the recreational market last summer. At the time, existing cannabis companies in the state switched to adult-use shops by paying an 8% one-time fee of their 2022 dispensary revenue not exceeding $2m. Licensed stores took in $20.9m in the first week of legal sales. In total, Maryland recorded $787.5m in sales of legal marijuana products in 2023. Over the same period, Rhode Islanders spent more than $107.8m on combined cannabis sales.
Cannabis stocks and ETFs opened higher on Tuesday following the release of documents related to the Department of Health and Human Service's (HHS) review of cannabis. Investors are optimistic about potential regulatory changes that could benefit the cannabis industry after the US government released 252 pages of documents confirming the HHS's recommendation that the DEA reschedule cannabis as Schedule III under the Controlled Substances Act. The documents state that cannabis has a currently accepted medical use in treatment and potential for abuse less than drugs in Schedules I and II. In August, the Assistant Secretary for Health wrote a letter to the DEA calling for marijuana to be reclassified. The Secretary of HHS has confirmed that his department shared a comprehensive scientific review with the DEA in response to President Joe Biden's scheduling directive.
Join Our Market Watch Newsletter!
Unlock Exclusive Market Insights! Receive timely updates on market developments. Sign up & stay informed!
Start typing to search
To view TrendSpider's complete data, please log into your TrendSpider account.